Human Immunodeficiency Virus Infections in the Middle East and North Africa: Prevalence, Risk, Prevention and Challenges

Journal Title: International Journal of Virology and AIDS - Year 2016, Vol 3, Issue 2

Abstract

Introduction/Objective: The Middle East and North Africa (MENA) has few recorded outputs regarding the prevalence of the human immunodeficiency viral (HIV) infections associated with acquired immune deficiency syndrome (AIDS). When we went through the HIV/AIDS in MENA, we found a hole in the scientific publications. Attention towards this issue progressed recently though, with few pre-clinical studies conducted. In the current review, we collected comprehensive data of HIV epidemiology in MENA and discussed the main challenges facing clinicians in charge with ailments in MENA and recommended some prevention strategies. The antiretroviral therapy (ART) has been present globally, thus delaying the world enterprise of providing new therapeutics and preventative candidates, even in rich nations such as Saudi Arabia. Methods: This review article following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and covering the most of MENA countries. PubMed, Embase, regional and international databases, as well as country-level reports were searched up to 2016. Primary studies reporting the prevalence/incidence of HIV, the prevalence of injecting or sexual risk behaviors, the proportion of risks in MENA, were eligible for inclusion. The quantity and geographic coverage of the data were assessed at country level. Prevention and challenges were also reported. Results and conclusion: Recently, numerous MENA countries did a remarkable effort to scale-up their awareness to this rising epidemic by developing tactics to tackle HIV and establishing national health-care programs. The scaling-up and developing of ART is very important in MENA. However, MENA has the lowest ART attention in the world, and the implementation of the WHO guidelines is likely to generate an even greater gap between those eligible for treatment and those receiving it, owing to either lack of medical awareness or adequate insurance, as well as cultural and social barriers. These issues stand as solid obstacles to effectively apply the HIV prevention system in MENA. Few countries in MENA have already established efficient programs to tackle HIV transmission from mothers to their kids, by frequent testing and care.

Authors and Affiliations

Keywords

Related Articles

HIV Exposed Uninfected Children at School Age: Developing Country Context

With the success of chemoprophylaxis for the prevention of perinatal transmission of the human immunodeficiency virus (HIV), an increasing number of HIV-exposed but uninfected (HEU) children will have in utero and post-p...

Comprehensive Programme to Prevent Cervical Cancer-the Case of Hungary

The overall purpose of a comprehensive cervical cancer prevention programme is to coordinate HPV vaccination (primary prevention) and cervical screening (secondary prevention). Harmonization of the HPV vaccination and po...

p53 Expression Activation of HIV-1 Latency in U1 Cells

Latent infection is a major barrier for cure of HIV-1 infection. HIV-1 is capable of establishing latency when its host cells undergo apoptosis and initiate replication in response to this effect. HIV infection results i...

Acute Pulmonary Embolism in Dual Dengue Fever and Influenza B Infection

Acute Pulmonary Embolism (PE) is a life-threatening condition and the common cause of death is due to obstruction of main pulmonary vessels by the embolus, resulting in pulmonary hypertension followed by right-sided hear...

Nucleoside Reverse Transcriptase Inhibitor (NRTI) Associated Macrocytosis

Macrocytosis has been associated with several disease states, vitamin deficiencies, and medications, with nucleoside reverse transcriptase inhibitors (NRTIs) being a less commonly identified cause. NRTIs are frequently u...

Download PDF file
  • EP ID EP354577
  • DOI 10.23937/2469-567X/1510027
  • Views 128
  • Downloads 0

How To Cite

(2016). Human Immunodeficiency Virus Infections in the Middle East and North Africa: Prevalence, Risk, Prevention and Challenges. International Journal of Virology and AIDS, 3(2), 1-4. https://europub.co.uk/articles/-A-354577